<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>N-<z:chebi fb="0" ids="30353">isopropyl</z:chebi>-p-[I-123] iodoamphetamine (I-123 IMP) SPECT studies were performed on a 75-year-old patient who could be clinically classified as subcortical arteriosclerotic <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> (<z:e sem="disease" ids="C0270786" disease_type="Disease or Syndrome" abbrv="">Binswanger's disease</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Regional cerebral blood flow (rCBF) was quantitatively measured by a microsphere model, and was diffusely decreased in the whole brain (mean rCBF: 36 ml/100 g/minute) </plain></SENT>
<SENT sid="2" pm="."><plain>After a ventriculoperitoneal shunt operation, his clinical symptoms were markedly improved, and the improvement was validated by a 32% increase of mean rCBF </plain></SENT>
<SENT sid="3" pm="."><plain>However, MRI and CT images showed no significant interval changes before and after the shunt operation </plain></SENT>
<SENT sid="4" pm="."><plain>Regional rCBF measurement by I-123 IMP SPECT should be performed and plays an important role in the evaluation of <z:e sem="disease" ids="C0270786" disease_type="Disease or Syndrome" abbrv="">Binswanger's disease</z:e> </plain></SENT>
</text></document>